100 related articles for article (PubMed ID: 12186432)
1. Detection of chimeric genes in Ewing's sarcoma and its clinical applications.
Kojima T; Asami S; Chin M; Yoshida Y; Mugishima H; Suzuki T
Biol Pharm Bull; 2002 Aug; 25(8):991-4. PubMed ID: 12186432
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma.
Yoshino N; Kojima T; Asami S; Motohashi S; Yoshida Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Kaneko M; Mugishima H; Suzuki T
Biol Pharm Bull; 2003 May; 26(5):585-8. PubMed ID: 12736494
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues.
Lewis TB; Coffin CM; Bernard PS
Mod Pathol; 2007 Mar; 20(3):397-404. PubMed ID: 17334332
[TBL] [Abstract][Full Text] [Related]
4. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma.
Downing JR; Khandekar A; Shurtleff SA; Head DR; Parham DM; Webber BL; Pappo AS; Hulshof MG; Conn WP; Shapiro DN
Am J Pathol; 1995 Mar; 146(3):626-34. PubMed ID: 7887445
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours.
Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; Winkelmann W; Strehl S; Burdach S; van Valen F; Jürgens H; Böcker W
Virchows Arch; 1994; 425(2):107-12. PubMed ID: 7524975
[TBL] [Abstract][Full Text] [Related]
6. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
7. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.
Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y
Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257
[TBL] [Abstract][Full Text] [Related]
8. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
9. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.
Downing JR; Head DR; Parham DM; Douglass EC; Hulshof MG; Link MP; Motroni TA; Grier HE; Curcio-Brint AM; Shapiro DN
Am J Pathol; 1993 Nov; 143(5):1294-300. PubMed ID: 8238248
[TBL] [Abstract][Full Text] [Related]
10. Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
Yabe H; Fukuma M; Urano F; Yoshida K; Kato S; Toyama Y; Hata J; Umezawa A
Biochem Biophys Res Commun; 2002 Apr; 293(1):61-71. PubMed ID: 12054564
[TBL] [Abstract][Full Text] [Related]
11. [Ewing's tumours, genetic and cellular aspects].
Delattre O
Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
[TBL] [Abstract][Full Text] [Related]
12. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
[TBL] [Abstract][Full Text] [Related]
13. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
[TBL] [Abstract][Full Text] [Related]
14. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
[TBL] [Abstract][Full Text] [Related]
15. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
16. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
Burchill SA
J Clin Pathol; 2003 Feb; 56(2):96-102. PubMed ID: 12560386
[TBL] [Abstract][Full Text] [Related]
18. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
[TBL] [Abstract][Full Text] [Related]
19. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
